丰硕种植业网 - 丰硕种植业网
蔬菜网-蔬菜行业商务平台
永盛农业种植网 - 永盛农业种植网
CN蔬菜网 - 国内蔬菜供求信息发布、蔬菜商情查询平台（VIP蔬菜网)
水果资讯网 - 专业分享各种瓜果蔬菜资讯的网站！
萌桥农业种植网 - 萌桥农业种植网
该站点未添加描述description...
国阳云，做更放心的云通讯服务商。平台稳定，接口完善，短信验证码，语音验证码秒发秒到。可免费接受上行短信，查看短信状态报告。短信api接口提供多种功能，短信模板丰富，网络短信到达率98%，上万家企业短信的选择。
大爪猫游戏,盘吉吉论坛,西瓜传奇单机版
该站点未添加描述description...
国际节能环保网全面展示节能领域的企事业单位,及时宣传报道国内外最新成果,汇集国内外最新发展动态,推广实用技术,典型案例和示范项目。
该站点未添加描述description...
弘英培训
该站点未添加描述description...
青岛佳德工业设备有限公司2005年进入工业铝型材行业，是青岛地区较早从事欧标铝型材工装应用开发的公司。为几十家自动化和大型设备公司制作机架、安全围栏、安全防护罩产品，赢得本地众多客户的信任和好评。
WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.